HC Wainwright Has Negative Forecast for PRAX Q2 Earnings
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2025 EPS estimates for Praxis Precision Medicines in a research report issued on Monday, May 5th. HC Wainwright analyst D. Tsao now expects that the company will earn ($3.83) per share for the quarter, down from their previous […]
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2025 EPS estimates for Praxis Precision Medicines in a research report issued on Monday, May 5th. HC Wainwright analyst D. Tsao now expects that the company will earn ($3.83) per share for the quarter, down from their previous […]
